Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Number of holders
-
197
-
Total 13F shares, excl. options
-
47,679,245
-
Shares change
-
+6,398,515
-
Total reported value, excl. options
-
$1,810,642,238
-
Value change
-
+$238,092,658
-
Put/Call ratio
-
68.21%
-
Number of buys
-
114
-
Number of sells
-
-83
-
Price
-
$37.97
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2018
248 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q4 2018.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 197 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47,679,245 shares
of 67,604,359 outstanding shares and own 70.53% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (5,662,982 shares), BlackRock Inc. (4,201,695 shares), FRED ALGER MANAGEMENT INC (3,184,080 shares), LORD, ABBETT & CO. LLC (1,810,966 shares), FEDERATED INVESTORS INC /PA/ (1,710,032 shares), TimesSquare Capital Management, LLC (1,640,570 shares), RENAISSANCE TECHNOLOGIES LLC (1,412,327 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1,312,885 shares), STATE STREET CORP (1,275,179 shares), and Point72 Asset Management, L.P. (1,206,107 shares).
This table shows the top 197 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.